Terms: = Lung cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Staging
9 results:
1. CTNNB1 p.D32A (c.95A > C) somatic mutation in stage I grade 1 endometrioid endometrial carcinoma with lung metastasis: a case report.
Zhong L; Jiang W; RutieYin ; Liu H; Song L
BMC Med Genomics; 2023 Jun; 16(1):137. PubMed ID: 37328769
[TBL] [Abstract] [Full Text] [Related]
2. lncRNA ZEB2-AS1 Aggravates Progression of Non-Small Cell lung Carcinoma via Suppressing pten Level.
Chen X; Wang K
Med Sci Monit; 2019 Nov; 25():8363-8370. PubMed ID: 31695021
[TBL] [Abstract] [Full Text] [Related]
3. mRNA expression of programmed cell death ligand 1 and components of the phosphatidylinositol 3-kinase/AKT/phosphatase and tensin homolog pathway in epidermal growth factor receptor mutation-positive lung adenocarcinoma.
Han K; Zhang Y
J Cancer Res Ther; 2019; 15(4):914-920. PubMed ID: 31436252
[TBL] [Abstract] [Full Text] [Related]
4. Phosphatase and tensin homolog protein may be linked to lymph node metastasis and tumor node metastasis staging in nonsmall cell lung cancer.
Ji ZY; Li HF; Lei Y; Rao YW; Sun ML; Wang XW; Zhang YL
J Cancer Res Ther; 2018; 14(Supplement):S138-S144. PubMed ID: 29578164
[TBL] [Abstract] [Full Text] [Related]
5. Role of exon 7 pten Gene in Endometrial Carcinoma.
Kafshdooz L; Kafshdooz T; Tabrizi AD; Mohaddes Ardabili SM; Akbarzadeh A; Gharesouran J; Ghojazadeh M; Farajnia S
Asian Pac J Cancer Prev; 2015; 16(11):4521-4. PubMed ID: 26107197
[TBL] [Abstract] [Full Text] [Related]
6. Expression and clinical evidence of miR-494 and pten in non-small cell lung cancer.
Wang J; Chen H; Liao Y; Chen N; Liu T; Zhang H; Zhang H
Tumour Biol; 2015 Sep; 36(9):6965-72. PubMed ID: 25861022
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic and predictive biomarkers in lung cancer. A review.
Thunnissen E; van der Oord K; den Bakker M
Virchows Arch; 2014 Mar; 464(3):347-58. PubMed ID: 24420742
[TBL] [Abstract] [Full Text] [Related]
8. TOPK/PBK promotes cell migration via modulation of the PI3K/pten/AKT pathway and is associated with poor prognosis in lung cancer.
Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
[TBL] [Abstract] [Full Text] [Related]
9. Phosphorylated GSK3beta-ser9 and EGFR are good prognostic factors for lung carcinomas.
Zheng H; Saito H; Masuda S; Yang X; Takano Y
Anticancer Res; 2007; 27(5B):3561-9. PubMed ID: 17972518
[TBL] [Abstract] [Full Text] [Related]
